NCOA3 and neoplasm: In addition, if we discuss IMPC tumors in terms of SRC-3 activity and levels, although the direct effects of SRC-3 in IMPC pathogenesis are not yet known, it is highly likely that it is tumor-promoting, since it both controls the expression of HER2 and is a co-activator of the ER.